The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in identifying IDH-mutant and IDH-wild-type gliomas were 80%, 77%, 86%, and 70%, respectively (Table 2). Here, IDH2 is linked to central nervous system cancer.